Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement ; volume:30 ; number:12 ; day:5 ; month:11 ; year:2022 ; pages:9877-9888 ; date:12.2022
Supportive care in cancer ; 30, Heft 12 (5.11.2022), 9877-9888, 12.2022
- Creator
-
Adamo, Vincenzo
Antonuzzo, Lorenzo
Danova, Marco
Laurentiis, Michelino De
Marchetti, Paolo
Pinto, Carmine
Rosti, Giovanni
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-022-07430-7
- URN
-
urn:nbn:de:101:1-2023021021442337212943
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Adamo, Vincenzo
- Antonuzzo, Lorenzo
- Danova, Marco
- Laurentiis, Michelino De
- Marchetti, Paolo
- Pinto, Carmine
- Rosti, Giovanni
- SpringerLink (Online service)
Other Objects (12)
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Febrile neutropenia : with 32 tables
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Febrile neutropenia : with 32 tables
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer